FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Deanna Kelly

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Living Beings

Young Adult

Physiology

Drug Resistance

Co-author Network

Publications

TOP 3
Maju Mathew Koola; Clifford Qualls; Kelly Skelton; Richard Amar; Bekh Bradley; Deanna L Kelly; Erica J Duncan
Prevalence of childhood physical and sexual abuse in veterans with psychiatric diagnoses.
Mary R Lee; Jared Linthicum; Fang Liu; Robert P McMahon; Gregory Strauss; Heidi Wehring; Alan S Bellack; Robert W Buchanan; Nicola G Cascella; Carlo Contoreggi; Deanna L Kelly
Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.
William R Keller; Maju Mathew Koola; Lionel M Kum; Heidi Wehring; Robert W Buchanan; Deanna L Kelly
A review of anti-inflammatory agents for symptoms of schizophrenia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Deanna Kelly (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Maju Mathew Koola; Clifford Qualls; Kelly Skelton; Richard Amar; Bekh Bradley; Deanna L Kelly; Erica J Duncan
Prevalence of childhood physical and sexual abuse in veterans with psychiatric diagnoses.
The Journal of nervous and mental disease 2013;201(4):348-52.
2013: Mary R Lee; Jared Linthicum; Fang Liu; Robert P McMahon; Gregory Strauss; Heidi Wehring; Alan S Bellack; Robert W Buchanan; Nicola G Cascella; Carlo Contoreggi; Deanna L Kelly
Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.
Schizophrenia research 2013;145(1-3):110-5.
2013: William R Keller; Maju Mathew Koola; Lionel M Kum; Heidi Wehring; Robert W Buchanan; Deanna L Kelly
A review of anti-inflammatory agents for symptoms of schizophrenia.
Journal of psychopharmacology (Oxford, England) 2013;27(4):337-42.
2013: Kimberly R Warren; Jared Linthicum; Fang Liu; Robert P McMahon; M Patricia Ball; Robert W Buchanan; Robert R Conley; Stephanie Feldman; David A Gorelick; Marilyn A Huestis; Deanna L Kelly
Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study.
Journal of clinical psychopharmacology 2013;33(1):118-20.
2013: Douglas L Boggs; Deanna L Kelly; Jared A Linthicum; Fang Liu; Robert P McMahon; Jennifer R Schroeder; Hailey Turner; David A Gorelick
Cannabis withdrawal in chronic cannabis users with schizophrenia.
Journal of psychiatric research 2013;47(2):240-5.
2013: David A Gorelick; Denis Bonnet; William D Darwin; Robert S Goodwin; Deanna L Kelly; Fang Liu; Robert P McMahon; Catherine Ortemann-Renon; Eugene W Schwilke; David M Schwope; Marilyn A Huestis
Tolerance to effects of high-dose oral δ9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers.
Journal of analytical toxicology 2013;37(1):11-6.
2012: Erin L Karschner; Deanna L Kelly; Eugene W Schwilke; David M Schwope; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.
Drug and alcohol dependence 2012;125(3):313-9.
2012: Jessica Jackson; William T Carpenter; Nicola G Cascella; William W Eaton; Alessio Fasano; Stephanie Feldman; Jared Linthicum; Charles Richardson; Debby Santora; Gopal Vyas; Dale Warfel; Kimberly R Warren; Deanna L Kelly
A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies.
Schizophrenia research 2012;140(1-3):262-3.
2012: Michael T Abrams; Cynthia Boddie-Willis; Stephanie M Feldman; Robert P McMahon; Carol S Myers; Junyong Park; Deanna L Kelly
Cervical cancer screening and acute care visits among Medicaid enrollees with mental and substance use disorders.
Psychiatric services (Washington, D.C.) 2012;63(8):815-22.
2012: Maju Mathew Koola; Fang Liu; Raymond Charles Love; Kristen M Mackowick; Robert P McMahon; Joo-Cheol Shim; Kimberly R Warren; Heidi Wehring; Stephanie Feldman; Deanna L Kelly
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders.
Journal of psychiatric research 2012;46(8):987-93.
2012: Kristen M Mackowick; Robert P McMahon; Heidi Wehring; STEPHEN HEISHMAN; Fang Liu; Deanna L Kelly
Illicit drug use in heavy smokers with and without schizophrenia.
Schizophrenia research 2012;139(1-3):194-200.
2012: Heidi Wehring; Lisa Dixon; Fang Liu; Raymond Charles Love; Kristen M Mackowick; Robert P McMahon; Deanna L Kelly
Clinical characteristics of heavy and non-heavy smokers with schizophrenia.
Schizophrenia research 2012;138(2-3):285-9.
2012: David A Gorelick; STEPHEN HEISHMAN; Douglas L Boggs; Marc L Copersino; Kenneth H Levin; Fang Liu; Deanna L Kelly
Diagnostic criteria for cannabis withdrawal syndrome.
Drug and alcohol dependence 2012;123(1-3):141-7.
2012: Maju Mathew Koola; Ngoc-Anh Le; Clifford Qualls; Jeffrey Raines; W Virgil Brown; Bruce Cuthbert; Jeffrey P Hollis; Deanna L Kelly; Erica J Duncan
Reduced arterial compliance in patients with psychiatric diagnoses.
Schizophrenia research 2012;137(1-3):251-3.
2012: Deanna L Kelly; Fang Liu; Suzanne Lo; Robert P McMahon; Eric T. Moolchan; Heather G Raley; Charles M Richardson; Heidi Wehring; Katherine Wright; Stephanie Feldman; STEPHEN HEISHMAN
Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia.
Schizophrenia bulletin 2012;38(3):543-51.
2012: Jessica R Jackson; Nicola G Cascella; William W Eaton; Alessio Fasano; Deanna L Kelly
Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity.
The Psychiatric quarterly 2012;83(1):91-102.
2012: Douglas L Boggs; Robert R Conley; James M Gold; David A Gorelick; Marilyn A Huestis; Deanna L Kelly; Jared Linthicum; Fang Liu; Robert P McMahon; James A Waltz; Robert W Buchanan
Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial.
Schizophrenia research 2012;134(2-3):207-10.
2012: Joo-Cheol Shim; Ji-Heon Lee; Sung-Soo Jung; Bo-Geum Kong; Sang-Duk Kim; Deuk-Man Cho; Do-Un Jung; Je-Wook Kang; Sae-Woom Lee; Young-Soo Seo; Min-Kyung Oh; Robert P McMahon; Deanna L Kelly
Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2012;37(3):660-8.
2012: Robert S Goodwin; David A Gorelick; Michael H Baumann; Denis Bonnet; William D Darwin; Deanna L Kelly; Catherine Ortemann-Renon; Jennifer R Schroeder; Eugene W Schwilke; David M Schwope; Marilyn A Huestis
CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men.
The American journal of drug and alcohol abuse 2012;38(1):114-9.
2011: Maju Mathew Koola; Jan A Fawcett; Deanna L Kelly
Case report on the management of depression in schizoaffective disorder, bipolar type focusing on lithium levels and measurement-based care.
The Journal of nervous and mental disease 2011;199(12):989-90.
2011: Deanna L Kelly; Maju Koola; Robert P McMahon; Charles M Richardson; Gopal Vyas; Robert W Buchanan; Heidi Wehring
Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms.
Schizophrenia research 2011;133(1-3):257-8.
2011: Garry Milman; Eugene W Schwilke; David M Schwope; Deanna L Kelly; William D Darwin; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.
Clinical chemistry 2011;57(11):1597-606.
2011: David A Gorelick; Denis Bonnet; William D Darwin; Robert S Goodwin; Deanna L Kelly; Fang Liu; Robert P McMahon; Catherine Ortemann-Renon; Eugene Schwilke; David M Schwope; Marilyn A Huestis
Antagonist-elicited cannabis withdrawal in humans.
Journal of clinical psychopharmacology 2011;31(5):603-12.
2011: Kimberly R Warren; M Patricia Ball; Stephanie Feldman; Fang Liu; Robert P McMahon; Deanna L Kelly
Exercise program adherence using a 5-kilometer (5K) event as an achievable goal in people with schizophrenia.
Biological research for nursing 2011;13(4):383-90.
2011: Deanna L Kelly; Sheryl Thedford; Gopal Vyas
A new blood-based diagnostic aid for schizophrenia.
Psychiatric services (Washington, D.C.) 2011;62(9):1107.
2011: Do-Un Jung; Je-Wook Kang; Deanna L Kelly; Bo-Geum Kong; Seung-Ju Lee; Min-Kyung Oh; Joo-Cheol Shim
Bone mineral density and osteoporosis risk in older patients with schizophrenia.
Journal of clinical psychopharmacology 2011;31(4):406-10.
2011: Deanna L Kelly; Fang Liu; Raymond Charles Love; Kristen M Mackowick; Robert P McMahon; Joo-Cheol Shim; Kimberly R Warren; Heidi Wehring; Douglas L Boggs; Stephanie Feldman; Lisa Dixon
Cigarette smoking and mortality risk in people with schizophrenia.
Schizophrenia bulletin 2011;37(4):832-8.
2011: Elaine Weiner; Alison Buchholz; Agnes Coffay; Fang Liu; Robert P McMahon; Robert W Buchanan; Deanna L Kelly
Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study.
Schizophrenia research 2011;129(1):94-5.
2011: M Patricia Ball; Kimberly R Warren; Stephanie Feldman; Robert P McMahon; Deanna L Kelly; Robert W Buchanan
Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine.
Clinical schizophrenia & related psychoses 2011;5(1):17-25.
2011: Suzanne Lo; STEPHEN HEISHMAN; Heather Raley; Katherine Wright; Heidi Wehring; Eric T. Moolchan; Stephanie Feldman; Fang Liu; Robert P McMahon; Charles M Richardson; Deanna L Kelly
Tobacco craving in smokers with and without schizophrenia.
Schizophrenia research 2011;127(1-3):241-5.
2011: Deanna L Kelly; Carol S Myers; M T Abrams; S Feldman; J Park; Robert P McMahon; Joo-Cheol Shim
The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2011;22(4):1133-43.
2011: Deanna L Kelly; David A Gorelick; Robert R Conley; Douglas L Boggs; Jared Linthicum; Fang Liu; Stephanie Feldman; M Patricia Ball; Heidi Wehring; Robert P McMahon; Marilyn A Huestis; STEPHEN HEISHMAN; Kimberly R Warren; Robert W Buchanan
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study.
Journal of clinical psychopharmacology 2011;31(1):86-91.
2011: Nicola G Cascella; Debra Kryszak; Bushra Bhatti; Patricia Gregory; Deanna L Kelly; Joseph P Mc Evoy; Alessio Fasano; William W Eaton
Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population.
Schizophrenia bulletin 2011;37(1):94-100.
2010: Heidi Wehring; Fang Liu; Robert P McMahon; Elena A Spieker; Kimberly R Warren; Douglas L Boggs; Raymond Charles Love; Dwight Dickinson; Joo-Cheol Shim; David Fowler; Deanna L Kelly
The relationship of brain weight to body mass index (BMI) upon autopsy in young people with severe mental illness.
Schizophrenia research 2010;123(1):86-7.
2010: Elaine Weiner; Robert R Conley; M Patricia Ball; Stephanie Feldman; James M Gold; Deanna L Kelly; Ikwunga Wonodi; Robert P McMahon; Robert W Buchanan
Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(11):2274-83.
2010: Kenneth H Levin; Marc L Copersino; STEPHEN HEISHMAN; Fang Liu; Deanna L Kelly; Douglas Boggs; David A Gorelick
Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers.
Drug and alcohol dependence 2010;111(1-2):120-7.
2010: Garry Milman; Allan J Barnes; David M Schwope; Eugene W Schwilke; William D Darwin; Robert S Goodwin; Deanna L Kelly; David A Gorelick; Marilyn A Huestis
Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.
Clinical chemistry 2010;56(8):1261-9.
2010: Deanna L Kelly; Stephanie Feldman; Douglas L Boggs; Elizabeth Gale; Robert R Conley
Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.
Comprehensive psychiatry 2010;51(3):298-302.
2010: Deanna L Kelly; Robert P McMahon; Fang Liu; Raymond Charles Love; Heidi Wehring; Joo-Cheol Shim; Kimberly R Warren; Robert R Conley
Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study.
The Journal of clinical psychiatry 2010;71(3):304-11.
2010: Robert W Buchanan; Julie Kreyenbuhl; Deanna L Kelly; Jason M. Noel; Douglas L Boggs; Bernard A IV Fischer; Seth Himelhoch; Beverly Fang; Eunice Peterson; Patrick R Aquino; William Keller
The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements.
Schizophrenia bulletin 2010;36(1):71-93.
2009: Eugene W Schwilke; David M Schwope; Erin L Karschner; Ross H Lowe; William D Darwin; Deanna L Kelly; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.
Clinical chemistry 2009;55(12):2180-9.
2009: Deanna L Kelly; Elaine Weiner; M Patricia Ball; Robert P McMahon; William T Carpenter; Robert W Buchanan
Remission in schizophrenia: the relationship to baseline symptoms and changes in symptom domains during a one-year study.
Journal of psychopharmacology (Oxford, England) 2009;23(4):436-41.
2009: Deanna L Kelly; Robert W Buchanan; Douglas L Boggs; Robert P McMahon; Dwight Dickinson; Matthew Nelson; James M Gold; M Patricia Ball; Stephanie Feldman; Fang Liu; Robert R Conley
A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia.
The Journal of clinical psychiatry 2009;70(4):518-25.
2009: Robert R Conley; Douglas L Boggs; Deanna L Kelly; Robert P McMahon; Dwight Dickinson; Stephanie Feldman; M Patricia Ball; Robert W Buchanan
The effects of galantamine on psychopathology in chronic stable schizophrenia.
Clinical neuropharmacology 2009;32(2):69-74.
2009: Deanna L Kelly; Heidi Wehring; Jared Linthicum; Stephanie Feldman; Robert P McMahon; Raymond Charles Love; Tara Wagner; Joo-Cheol Shim; David R Fowler
Cardiac-related findings at autopsy in people with severe mental illness treated with clozapine or risperidone.
Schizophrenia research 2009;107(2-3):134-8.
2008: Deanna L Kelly; Robert P McMahon; Elaine Weiner; Douglas L Boggs; Dwight Dickinson; Robert R Conley; Robert W Buchanan
Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia.
Schizophrenia research 2008;103(1-3):161-8.
2008: Joo-Cheol Shim; Young-Sun You; Deanna L Kelly
Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report.
Journal of clinical psychopharmacology 2008;28(3):353-4.
2008: Douglas L Boggs; Deanna L Kelly; Raymond Charles Love; Robert P McMahon; Robert R Conley
Comparison of clozapine response for inpatients in the research setting versus routine clinical practice.
The Psychiatric quarterly 2008;79(2):111-9.
2008: Deanna L Kelly; Robert R Conley; Raymond Charles Love; John A Morrison; Robert P McMahon
Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2008;20(2):71-8.
2008: Douglas L Boggs; Deanna L Kelly; Stephanie Feldman; Robert P McMahon; Matthew W Nelson; Yang Yu; Robert R Conley
Quetiapine at high doses for the treatment of refractory schizophrenia.
Schizophrenia research 2008;101(1-3):347-8.
2008: Robert P McMahon; Deanna L Kelly; Douglas L Boggs; Lan Li; Qiaoyan Hu; John M Davis; William T Carpenter
Feasibility of reducing the duration of placebo-controlled trials in schizophrenia research.
Schizophrenia bulletin 2008;34(2):292-301.
2007: Joo-Cheol Shim; Jae-Gook Shin; Deanna L Kelly; Do-Un Jung; Young-Soo Seo; Kwang-Hyeon Liu; Ji-Hong Shon; Robert R Conley
Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
The American journal of psychiatry 2007;164(9):1404-10.
2007: Deanna L Kelly; Douglas L Boggs; Robert R Conley
Reaching for wellness in schizophrenia.
The Psychiatric clinics of North America 2007;30(3):453-79.
2007: Deanna L Kelly; Julie Kreyenbuhl; Lisa Dixon; Raymond Charles Love; Deborah R Medoff; Robert R Conley
Clozapine underutilization and discontinuation in African Americans due to leucopenia.
Schizophrenia bulletin 2007;33(5):1221-4.
2007: Joo-Cheol Shim; Byeong Moo Choe; Jung Gee Kim; Young Myo Jae; Ho Chan Kim; Sung Gon Kim; Min Kyung Oh; Deanna L Kelly; Robert R Conley
Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis.
Journal of clinical psychopharmacology 2007;27(4):400-1.
2007: Robert R Conley; Deanna L Kelly
Drug-drug interactions associated with second-generation antipsychotics: considerations for clinicians and patients.
Psychopharmacology bulletin 2007;40(1):77-97.
2006: Deanna L Kelly
Treatment considerations in women with schizophrenia.
Journal of women's health (2002) 2006;15(10):1132-40.
2006: Deanna L Kelly; Lisa Dixon; Julie Kreyenbuhl; Deborah R Medoff; Anthony Lehman; Raymond Charles Love; Clayton H Brown; Robert R Conley
Clozapine utilization and outcomes by race in a public mental health system: 1994-2000.
The Journal of clinical psychiatry 2006;67(9):1404-11.
2006: Do-Un Jung; Robert R Conley; Deanna L Kelly; Dong-Wook Kim; Seong-Hwan Yoon; Jung-Hoon Jang; Jae-Gook Shin; Joo-Cheol Shim
Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional study.
The Journal of clinical psychiatry 2006;67(9):1391-6.
2006: Deanna L Kelly; Charles M Richardson; Yang Yu; Robert R Conley
Plasma concentrations of high-dose olanzapine in a double-blind crossover study.
Human psychopharmacology 2006;21(6):393-8.
2006: Deanna L Kelly; Robert R Conley
A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia.
Psychoneuroendocrinology 2006;31(3):340-6.
2006: Deanna L Kelly; Robert R Conley; Stephanie Feldman; Yang Yu; Robert P McMahon; Charles M Richardson
Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia.
The Psychiatric quarterly 2006;77(1):81-95.
2005: Do-Un Jung; Young-Soo Seo; Jae-Hoon Park; Chi-Young Jeong; Robert R Conley; Deanna L Kelly; Joo-Cheol Shim
The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophrenia.
Journal of clinical psychopharmacology 2005;25(6):613-5.
2005: Robert R Conley; Joo-Cheol Shim; Deanna L Kelly; Stephanie Feldman; Yang Yu; Robert P McMahon
Cardiovascular disease in relation to weight in deceased persons with schizophrenia.
Comprehensive psychiatry 2005;46(6):460-7.
2005: Robert R Conley; Deanna L Kelly; Matthew W Nelson; Charles M Richardson; Stephanie Feldman; Rhonda Benham; Patricia Steiner; Yang Yu; Ijaz A Khan; Ron McMullen; Elizabeth Gale; Marie Mackowick; Raymond Charles Love
Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia.
Clinical neuropharmacology 2005;28(4):163-8.
2005: Robert R Conley; Deanna L Kelly; Tim J Lambert; Raymond Charles Love
Comparison of clozapine use in Maryland and in Victoria, Australia.
Psychiatric services (Washington, D.C.) 2005;56(3):320-3.
2005: Robert R Conley; Deanna L Kelly
Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.
The Israel journal of psychiatry and related sciences 2005;42(1):51-60.
2005: Joo-Cheol Shim; Young-Hoon Kim; Deanna L Kelly; Jung-Goo Lee; Robert R Conley
Tardive dyskinesia predicts prolactin response to buspirone challenge in people with schizophrenia.
The Journal of neuropsychiatry and clinical neurosciences 2005;17(2):221-6.
2005: Deanna L Kelly; Robert R Conley; William T Carpenter
First-episode schizophrenia: a focus on pharmacological treatment and safety considerations.
Drugs 2005;65(8):1113-38.
2005: Deanna L Kelly; Robert R Conley
Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine.
The Journal of clinical psychiatry 2005;66(1):80-4.
2004: Deanna L Kelly; Joo-Cheol Shim; Stephanie M Feldman; Yang Yu; Robert R Conley
Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death.
Journal of psychiatric research 2004;38(5):531-6.
2004: Robert R Conley; Deanna L Kelly; Lori L Beason-Held; Henry H Holcomb; Charles M Richardson
The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study.
Journal of psychopharmacology (Oxford, England) 2004;18(3):429-31.
2004: Young-Hoon Kim; Joo-Cheol Shim; Deanna L Kelly; Jeong Goo Lee; Young-Soo Seo; Robert R Conley
Cortisol response to buspirone in extended abstinent alcoholics.
Alcohol and alcoholism (Oxford, Oxfordshire) 2004;39(4):287-9.
2004: Tim Lambert; Deanna L Kelly; Shelda Alcock; Robert R Conley
Psychotropic prescribing for acute inpatient admissions in patients with severe psychosis.
Journal of clinical psychopharmacology 2004;24(1):91-3.
2004: Deanna L Kelly; Robert R Conley
Sexuality and schizophrenia: a review.
Schizophrenia bulletin 2004;30(4):767-79.
2004: Deanna L Kelly; Raymond Charles Love; Marie Mackowick; Robert P McMahon; Robert R Conley
Atypical antipsychotic use in a state hospital inpatient adolescent population.
Journal of child and adolescent psychopharmacology 2004;14(1):75-85.
2003: Heidi Wehring; Deanna L Kelly; Raymond Charles Love; Robert R Conley
Deaths from diabetic ketoacidosis after long-term clozapine treatment.
The American journal of psychiatry 2003;160(12):2241-2.
2003: Robert R Conley; Deanna L Kelly; Charles M Richardson; Carol A Tamminga; William T Carpenter
The efficacy of high-dose olanzapine versus clozapine in treatment-resistant schizophrenia: a double-blind crossover study.
Journal of clinical psychopharmacology 2003;23(6):668-71.
2003: Matthew W Nelson; Rhonda R Reynolds; Deanna L Kelly; Robert R Conley
Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.
Clinical neuropharmacology 2003;26(6):297-8.
2003: Joo-Cheol Shim; Deanna L Kelly; Young-Hoon Kim; Young-Ran Yoon; Jeong-Hwan Park; Jae-Gook Shin; Robert R Conley
Fluoxetine augmentation of haloperidol in chronic schizophrenia.
Journal of clinical psychopharmacology 2003;23(5):520-2.
2003: Deanna L Kelly; Robert R Conley; Charles M Richardson; Carol A Tamminga; William T Carpenter
Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2003;15(3-4):181-6.
2003: Deanna L Kelly; Julie Kreyenbuhl; Raymond Charles Love; Quynh Van-Duong; Robert R Conley
Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.
The Journal of clinical psychiatry 2003;64(9):1133-4.
2003: Deanna L Kelly; Robert R Conley
Evaluating sexual function in patients with treatment-resistant schizophrenia.
Schizophrenia research 2003;63(1-2):195-6.
2003: T J R Lambert; N Cock; S J Alcock; Deanna L Kelly; Robert R Conley
Measurement of antipsychotic-induced side effects: support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement.
Human psychopharmacology 2003;18(5):405-11.
2003: Tim Lambert; Ann Brennan; David J Castle; Deanna L Kelly; Robert R Conley
Perception of depot antipsychotics by mental health professionals.
Journal of psychiatric practice 2003;9(3):252-60.
2003: Robert R Conley; Deanna L Kelly; Raymond Charles Love; Robert P McMahon
Rehospitalization risk with second-generation and depot antipsychotics.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2003;15(1):23-31.
2003: Deanna L Kelly; Elizabeth A Gale; Robert R Conley
Clozapine treatment in patients with prior substance abuse.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2003;48(2):111-4.
2003: Raymond Charles Love; Deanna L Kelly
Olanzapine and risperidone.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2003;60(5):487-8; author reply 488-9.
2002: Julie Kreyenbuhl; Deanna L Kelly; Robert R Conley
Circumstances of suicide among individuals with schizophrenia.
Schizophrenia research 2002;58(2-3):253-61.
2002: Robert R Conley; Deanna L Kelly
Current status of antipsychotic treatment.
Current drug targets. CNS and neurological disorders 2002;1(2):123-8.
2002: Robert P McMahon; Deanna L Kelly; Julie Kreyenbuhl; Brian Kirkpatrick; Raymond Charles Love; Robert R Conley
Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(4):537-45.
2001: Robert R Conley; Deanna L Kelly
Management of treatment resistance in schizophrenia.
Biological psychiatry 2001;50(11):898-911.
2001: C Richardson; Deanna L Kelly; Robert R Conley
Biperiden for excessive sweating from clozapine.
The American journal of psychiatry 2001;158(8):1329-30.
2001: R R Conley; Deanna L Kelly
Treatment of the special patient with schizophrenia.
Dialogues in clinical neuroscience 2001;3(2):123-35.
2001: Deanna L Kelly; Matthew W Nelson; Raymond Charles Love; Yang Yu; Robert R Conley
Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine.
Psychiatric services (Washington, D.C.) 2001;52(5):676-8.
2001: Deanna L Kelly; Raymond Charles Love
Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.
Psychopharmacology bulletin 2001;35(4):66-79.
1999: Deanna L Kelly; Robert R Conley; Carol A Tamminga
Differential olanzapine plasma concentrations by sex in a fixed-dose study.
Schizophrenia research 1999;40(2):101-4.
1999: Raymond Charles Love; Robert R Conley; Deanna L Kelly; John J Bartko
A dose-outcome analysis of risperidone.
The Journal of clinical psychiatry 1999;60(11):771-5.
1999: Robert R Conley; Carol A Tamminga; Deanna L Kelly; Charles M Richardson
Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response.
Biological psychiatry 1999;46(1):73-7.
1999: Robert R Conley; Raymond Charles Love; Deanna L Kelly; John J Bartko
Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.
The American journal of psychiatry 1999;156(6):863-8.
1998: D B Moore; Deanna L Kelly; Jay D Sherr; Raymond Charles Love; Robert R Conley
Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: comparison with risperidone.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1998;55(24 Suppl 4):S17-9.
1998: Jay D Sherr; Deanna L Kelly
Substitution of immediate-release valproic acid for divalproex sodium for adult psychiatric inpatients.
Psychiatric services (Washington, D.C.) 1998;49(10):1355-7.
1998: Robert R Conley; Deanna L Kelly; E A Gale
Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse.
Schizophrenia research 1998;33(1-2):95-101.
1998: Deanna L Kelly; Robert R Conley; Raymond Charles Love; D S Horn; C M Ushchak
Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months.
Journal of child and adolescent psychopharmacology 1998;8(3):151-9.